Itopride Hydrochloride API specifications guide

Monograph differences and the checks worth running on incoming material.

Itopride Hydrochloride is a well-established prokinetic with steady generic demand, which means supplier selection turns less on the molecule and more on the discipline of the specification and the checks you run on incoming material. The salt form and the monograph you release against are where the practical differences sit.

What Itopride Hydrochloride is used for

Itopride is a prokinetic agent formulated for the symptomatic treatment of functional dyspepsia — the bloating, early satiety and upper-abdominal discomfort associated with non-ulcer dyspepsia. It is an oral solid, most often supplied as tablets.

For a formulator, the demand profile is predictable and largely generic, so the value you are buying is consistency of material and completeness of documentation rather than any novelty in the indication. That makes the incoming-goods checks and the specification the real levers.

The salt form and the identity you release against

Itopride is supplied as the hydrochloride salt, and the identity and assay tests should confirm both the base and the chloride. Ask the supplier to state the salt form explicitly on the specification and to name the identity methods used, so there is no ambiguity about what you are releasing.

An identity test that confirms only the Itopride moiety and is silent on the chloride is not a complete identity for a salt. Make sure the specification you evaluate demonstrates the full salt, not just the active portion.

Monograph differences that change a filing

Compendial coverage for Itopride Hydrochloride is not uniform across pharmacopoeias, so you may be releasing against a compendial monograph in one market and an in-house specification in another. Confirm which applies to your target market and which the quoted material is controlled to.

A price quoted against an in-house specification is not comparable to one quoted against a compendial grade — always ask which the number refers to.

The methods that demonstrate the limits differ with the specification, so a quotation without a stated grade is not comparable to one that has it. Pinning this down early prevents two quotations from looking further apart than they really are.

Incoming-material checks worth running

Before you release a lot, run identity, assay and the loss-on-drying or water-content test the specification calls for, and check the impurity results against stated limits rather than accepting a pass statement. For a hydrochloride salt, confirming the chloride content is part of a complete incoming check.

Because impurities follow the synthetic route, ask whether the route has changed recently — a route change hands you a new impurity profile to justify, which is a regulatory question before it is a quality one. Building this into your incoming procedure means a surprise shows up at goods-in, not in a stability chamber.

Documentation to request before the first PO

A batch Certificate of Analysis, the method of analysis, an MSDS and the product specification should be available before you order, with DMF or open-part documentation on request where your filing needs it. Confirm the CoA reports actual results against limits, not merely conformance statements.

How quickly and completely a supplier sends this set at enquiry stage is a reliable early signal. Documentation turnaround before the PO tends to predict documentation turnaround when you have a shipment held at a port.

A short checklist before you commit

• Confirm the salt form and that identity tests demonstrate both base and chloride.
• Ask which monograph or in-house specification the price is quoted against.
• Run identity, assay and water-content checks on incoming material against stated limits.
• Confirm whether the synthetic route has changed recently.
• Request a batch CoA reporting actual results before raising the PO.